LivaNova PLC (LIVN) Stock Analysis

LivaNova PLC (LIVN) is a publicly traded company in the HEALTHCARE sector. It trades at $73.33, carries a market capitalization of $4.05B, a price-to-earnings ratio of 37.66. This page summarizes the public market data, fundamentals, and frequently asked questions for LIVN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $73.33
• Market Cap: $4.05B
• P/E Ratio: 37.66
• EPS: $1.96
• 52-Week High: $75.81
• 52-Week Low: $41.02

Market Sentiment

LivaNova PLC currently has a Bullish sentiment score of 0.16.

About LivaNova PLC

LivaNova PLC (LIVN) is a leading global medical device company dedicated to creating innovative therapeutic solutions in the cardiac and neuromodulation sectors. Headquartered in London, UK, LivaNova harnesses cutting-edge technology and deep industry expertise to address pressing patient needs and enhance clinical outcomes in cardiology and neurology. The company operates across diverse international markets, focusing on strategic partnerships and continuous product development to drive sust...

GNG Research Analysis

GNG Research scores LivaNova PLC (LIVN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for LIVN.

Frequently Asked Questions

Does LIVN pay dividends?

LivaNova PLC (LIVN) does not currently pay a regular dividend.

What is LIVN's P/E ratio?

LivaNova PLC has a price-to-earnings (P/E) ratio of 37.66.

What is LIVN's market cap?

LivaNova PLC (LIVN) has a market capitalization of $4.05B with a current stock price of $73.33.